Sofosbuvir Completed Phase 3 Trials for Chronic Hepatitis C Virus (HCV) Infection / Cirrhosis, Decompensated Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02597166Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection